↓ Cooling
Health
🔮 Newsylist predicts: fades by tomorrow medium confidence
Brain-swelling disease carried by mosquitos is surging
6sources
6articles
4velocity
-74%since first seen
12h agofirst detected
Coverage (6)
- West Nile virus risk grows when mosquitoes thrive in backyards USA Today · 13h ago
- What to Know About West Nile Virus Johns Hopkins Bloomberg School of Public Health · 13h ago
- Texans could experience more than skin irritation from insect bites grahamleader.com · 13h ago
- We're Amid an Active West Nile Virus Season; Here's How to Protect Yourself and Your Family PR Newswire · 13h ago
- Tips for avoiding potentially serious mosquito-borne illnesses Medical Xpress · 13h ago
- Brain-swelling disease carried by mosquitos is surging New York Post · 13h ago broke it first
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
↓ Cooling
Health
🔮 holds
Everyone's talking about hormone therapy for menopause. Should I be on it?
Hormone replacement therapy use has nearly doubled since 2017 amid new guidelines and widespread public discussion.
↑ Rising
Health
🔮 fades
FDA approves 1st mRNA flu shot, from Moderna
The first mRNA-based influenza vaccine has received federal approval in the United States.
↑ Rising
Health
🔮 holds ✗
DNR Closes Additional Areas of Cunningham Falls State Park Following Second Beaver Attack
Two separate beaver attacks at Cunningham Falls State Park prompt additional closures in Maryland.
↓ Cooling
Health
🔮 fades
GLP-1 Drugs May Have a Hidden Effect on Your Eyes, Study Finds
New safety guidance and a lawsuit spotlight a possible eye‑risk link in popular GLP-1 weight‑loss drugs.
◼ Archived
Health
🔮 holds ✗
Pesticide exposure linked to higher risk of ALS, research finds
New research links occupational pesticide exposure to a significantly heightened risk of motor neuron diseases like ALS.
◼ Archived
Health
🔮 fades ✓
Breast cancer checks missing most women under 50 who are at risk, says study
Study finds NHS breast cancer guidelines miss 95% of high‑risk women under 50, sparking calls for review.